SynaXG, a Singapore-based deep-tech startup, has raised over US$20 million in its first funding round led by January Capital, Vertex Ventures, and Qualgro. Funds will go toward expanding SynaXG’s ...

The best defensive stocks to balance risk and return combine durable cash flows, essential services, and key growth metrics.

Palo Alto Networks is a large-cap tech stock that continues to grow revenue and earnings steadily. Is PANW stock still a good ...

Strategic AI Partnerships: Transforming the Future of Cybersecurity To view an enhanced version of this graphic, please visit ...

According to SNS Insider, “The Generative AI Cybersecurity Market is accelerating as organizations deploy AI-driven threat ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 6.2% in the afternoon session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal-Weight" and ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...

WASHINGTON, Dec 8 (Reuters) - The U.S. Federal Communications Commission said on Monday it may bar three major Chinese telecom companies from connecting to U.S. networks over efforts to prevent ...

The companies announced an expanded partnership to strengthen joint engineering efforts. Palo Alto Networks will now ...

Be quiet!’s new Light base dual chamber cases come in 600 and larger 900 versions with black and white colour options and a ...